<p>Prostate cancer treatment dates back almost treatment approaches is examined in the subse- 100years. However, in an era of rapid develop- quent chapters of this volume. ments and innovations in cancer research and Te text addresses the time-honoured h- uro-oncology, there is an increasing need to
Prostate Cancer
β Scribed by M. R. Alderson (auth.), Professor William Duncan (eds.)
- Publisher
- Springer-Verlag Berlin Heidelberg
- Year
- 1981
- Tongue
- English
- Leaves
- 200
- Series
- Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer 78
- Edition
- 1
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
In February 1980 the Royal College of Radiologists, London, held its Second Symposium on Clinical Oncology. The subject was Prostatic Cancer and this publication is based on the presenΒ tations at this meeting by leading authorities in the United Kingdom. The principal objective of these Symposia is to promote multiΒ disciplinary collaboration for the benefit of cancer patients. Awareness and understanding of advances in a broad range of subjects are essential to ensure the timely and effective appliΒ cation of new techniques in the prevention and treatment of all forms of cancer. Communication of this kind may also stimulate the creation of new ideas that may prove to be of more fundamental relevance to cancer research. Prostatic cancer has been afforded too little attention in the past, and its importance in Clinical Oncology has not been adequately recognised. And yet over the last 10 years considΒ erable progress has been recorded in our understanding of this disease and in its assessment and management. These achieveΒ ments are well documented in this collection of papers and the outstanding problems are also clearly indicated. It is acknowlΒ edged that the early diagnosis of prostatic cancer presents a continuing challenge, associated with the uncertainties that concern the clinical significance of 'latent' cancer of the prostate. The accurate assessment of the incidence and prevaΒ lence of the disease is extremely difficult and together these problems complicate the evaluation of the management of early or localised prostatic cancer.
β¦ Table of Contents
Front Matter....Pages I-X
Epidemiology....Pages 1-19
Morphology in Health and Disease....Pages 20-28
Growth Kinetics....Pages 29-43
Hormonal Relationships, Receptors, and Tumour Markers....Pages 44-59
Pathology and Natural History....Pages 60-75
Diagnostic Imaging....Pages 76-96
Lymphography....Pages 97-107
Nuclear Medicine....Pages 108-118
Surgery....Pages 119-131
Radiotherapy....Pages 132-153
Endocrine and Cytotoxic Therapy....Pages 154-172
Perspectives and Prospects....Pages 173-184
Back Matter....Pages 185-192
β¦ Subjects
Urology/Andrology; Oncology
π SIMILAR VOLUMES
<p>This issue of Radiation Medicine Rounds examines the latest advances in the use of radiation medicine in treatment of prostate cancer Prostate cancer is the most common cancer in males and radiation therapy is a major tool in the management of the disease. This issue of Radiation Medicine Rounds
This comprehensive and easy-to-read monograph is an authoritative update on clinical prostate cancer. It has been prepared by an international, multidisciplinary team at the invitation of the International Prostate Health Council think tank. The management of prostate cancer a" the most prevalent ty
Around 32,000 men in the UK are diagnosed with prostate cancer each year. It differs from most other cancers in the body, in that small areas of cancer within the prostate are very common and may not grow or cause any problems for many years. It is often it is diagnosed during a routine checkup so m
Prostate cancer (PCa) is a disease with high incidence and prevalence. Early detection of PCa has been an area for research to decrease its morbidity and mortality. The discovery of prostate specific antigen (PSA) revolutionized screening of PCa, which was largely dependent on detection of prostatic
<p><P>More than one in six men will develop prostate cancer in their lifetime. In recent years there has been an explosion of information regarding PSA screening and biomarkers for the disease. In Prostate Cancer Screening, Second Edition, the worldβs leading experts on prostate cancer detection upd